Who are we and what do we do?

As a global biopharmaceutical company, our activities touch many people’s lives. We work closely with all our stakeholders to understand their challenges and how we can combine our skills and resources to achieve a common goal: improved health.

Learn more

Why it’s important to stay connected

We believe that social media can play an important role in advancing public health and that pharmaceutical companies have a responsibility to engage more fully in social media. For that reason we use a variety of social media channels to engage with our audience.

Learn more

AZ Health Connections

  • US FDA Approves MOVANTIK™ (naloxegol) Tablets C-II 17 September 2014 01:22 BST

    On September 16, the US Food and Drug Administration approved MOVANTIK™ (naloxegol) tablets C-II as the first once-daily oral peripherally acting mu-opioid receptor antagonist (PAMORA) for the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain. Opioids play an important role in chronic pain relief by binding to mu-receptors...